Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran Lipid and Glucose Study

Journal of Endocrinological Investigation

Volumn 35, Issue 1, 2012, Pages 14-20

  Bozorgmanesh, M ^a   Hadaegh, F ^a   Sheikholeslami, F ^a   Azizi, F ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

All cause mortality; Cardiovascular disease; Diabetes; Population attributable fraction; Risk

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; IRAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROPORTIONAL HAZARDS MODEL; SCREENING; SELF REPORT;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; INCIDENCE; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PUBLIC HEALTH; RISK FACTORS; SURVIVAL RATE;

EID: 84861990484     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7728     Document Type: Article

References (41)

1. Grundy SM, Benjamin IJ, Burke GL, et al; Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999, 100: 1134-46. (Pubitemid 29416243)
2. Woodward M, Zhang X, Barzi F, et al Asia Pacific Cohort Studies Collaboration. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes care 2003, 26: 360-6. (Pubitemid 36929056)
3. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001, 161: 397-405.
4. Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health 2008, 8: 176.
5. Hadaegh F, Khalili D, Fahimfar N, Tohidi M, Eskandari F, Azizi F. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). J Endocrinol Invest 2009, 32: 724-30.
6. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes care 1993, 16: 642-52. (Pubitemid 23097217)
7. Yates T, Davies M, Khunti K. Preventing type 2 diabetes: can we make the evidence work? Postgrad Med J 2009, 85: 475-80.
8. Ma S, Cutter J, Tan CE, Chew SK, Tai ES. Associations of diabetes mellitus and ethnicity with mortality in a multiethnic Asian population: data from the 1992 Singapore National Health Survey. Am J Epidemiol 2003, 158: 543-52. (Pubitemid 37093230)
9. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27: 1047-53. (Pubitemid 38579764)
10. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing worid-a growing challenge. N Engl J Med 2007, 356: 213-5. (Pubitemid 46143224)
11. Safran MA, Vinicor F. The war against diabetes. How will we know if we are winning? Diabetes Care 1999, 22: 508-16. (Pubitemid 29106913)
12. Heller RF, Dobson AJ, Attia J, Page J. Impact numbers: measures of risk factor impact on the whole population from case-control and cohort studies. J Epidemiol Community Health 2002, 56: 606-10. (Pubitemid 34791478)
13. Walter SD. Calculation of attributable risks from epidemiological data. Int J Epidemiol 1978, 7: 175-82. (Pubitemid 8402325)
14. Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res 2001, 10: 195-216. (Pubitemid 32586161)
15. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998, 88: 15-9.
16. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241: 2035-8. (Pubitemid 9228506)
17. Northridge ME. Public health methods-attributable risk as a link between causality and public health action. Am J Public Health 1995, 85: 1202-4.
18. Rowe AK, Powell KE, Flanders WD. Why population attributable fractions can sum to more than one. Am J Prev Med 2004, 26: 243-9. (Pubitemid 38338676)
19. Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009, 10: 5.
20. Freedman DS, Kahn HS, Mei Z, et al. Relation of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 2007, 86: 33-40. (Pubitemid 47041590)
21. Hadaegh F, Harati H, Ghanbarian A, Azizi F. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil 2006, 13: 571-7. (Pubitemid 44162159)
22. Gibbons RJ, Abrams J, Chatterjee K, et al American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee on the Management of Patients With Chronic Stable Angina. ACCAHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003, 107: 149-58. (Pubitemid 36070948)
23. Braunwald E, Antman EM, Beasley JW, et al American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction-2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002, 106: 1893-900.
24. Genuth S, Alberti KG, Bennett P, et al Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes care 2003, 26: 3160-7.
25. Whaley M, Brubaker P, Otto R, Armstrong L (eds). ACSM's guidelines for exercise testing and prescription. Philadelphia: Lippincott Williams & Wilkins, 2006.
26. Redberg RF, Benjamin EJ, Bittner V, et al American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; Preventive Cardiovascular Nurses Association. ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. Circulation 2009, 120: 1296-336.
27. Natarajan S, Lipsitz SR, Rimm E. A simple method of determining confidence intervals for population attributable risk from complex surveys. Stat Med 2007, 26: 3229-39. (Pubitemid 47039783)
28. Altman DG, Bland JM. Statistics Notes: Interaction revisited: the difference between two estimates. BMJ 2003, 326: 219. (Pubitemid 36143396)
29. Moreira LB, Fuchs SC, Wiehe M, et al. Cardiovascular risk attributable to diabetes in southern Brazil: a population-based cohort study. Diabetes Care 2009, 32: 854-6.
30. Zhang XH, Lu ZL, Liu L. Coronary heart disease in China. Heart 2008, 94: 1126-31.
31. Fox CS, Coady S, Sorlie PD, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 2007, 115: 1544-50. (Pubitemid 46648639)
32. Dale AC, Nilsen TI, Vatten L, Midthjell K, Wiseth R. Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74 914 individuals in the HUNT 1 Study. Eur Heart J 2007, 28: 2924-9. (Pubitemid 350233026)
33. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006, 332: 73-8.
34. Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 2000, 23: 962-8. (Pubitemid 30480024)
35. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998, 88: 15-9.
36. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359: 1577-89.
37. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 1998, 21: 1167-72. (Pubitemid 28368527)
38. Hu G; DECODE Study Group. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 2003, 46: 608-17.
39. Oba S, Nagata C, Nakamura K, Takatsuka N, Shimizu H. Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in Japan. J Epidemiol 2008, 18: 197-203.
40. Saydah SH, Eberhardt MS, Loria CM, Brancati FL. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol 2002, 156: 714-9. (Pubitemid 35155177)
41. Will JC, Casper M. The contribution of diabetes to early deaths from ischemic heart disease: US gender and racial comparisons. Am J Public Health 1996, 86: 576-9. (Pubitemid 26125044)